Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2024 Annual Meeting | S19 - Epilepsy Clinical Trials and Long-term Studies

Monday 04/15/24
03:30 PM - 05:30 PM MDT Add To Calendar
Colorado Convention Center | 708/710/712
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Scientific Platform Session
Epilepsy/Clinical Neurophysiology (EEG)
 A group of abstracts covering a similar topic will be presented in an eight-minute oral format followed by four minutes of question and answer with the author. 
2.00 CME credits

Program Materials Program Evaluations

Event Timeline
03:30 PM - 03:42 PM MDT Speaker 2024 Dreifuss-Penry Epilepsy Award: This award recognizes physicians in the early stages of their careers who have made an independent contribution to epilepsy research.
Erin Caitlin Conrad, MD
03:42 PM - 03:54 PM MDT Abstract 002 - First-in-Human Trial of NRTX-1001 GABAergic Interneuron Cell Therapy for Treatment of Focal Epilepsy - Emerging Clinical Trial Results
Cory R Nicholas, PhD
03:54 PM - 04:06 PM MDT Abstract 003 - Efficacy and Safety of ES-481, a Novel TARP Inhibitor, in Drug-resistant Epilepsy: A Double-blind Randomized Placebo Controlled Phase IIa Trial
Terence John O'Brien, MD
04:06 PM - 04:18 PM MDT Abstract 004 - The Impact of Disease Severity on Responder Rates in a Phase 2b Study of XEN1101, a Potent, Selective Potassium Channel Opener, in Adults with Focal Epilepsy (X-TOLE)
Roger J. Porter, MD, FAAN
04:18 PM - 04:30 PM MDT Abstract 005 - Interim Long-term Safety and Efficacy of XEN1101, a Potent, Selective Potassium Channel Opener: Update from an Ongoing Open-label Extension of a Phase 2b Study (X-TOLE) in Adults with Focal Epilepsy
Jacqueline French, MD, FAAN
04:30 PM - 04:42 PM MDT Abstract 006 - Sex Steroid Hormone Serum Concentrations in Pregnant Women with Epilepsy in MONEAD
Paula Emanuela Voinescu, MD
04:42 PM - 04:54 PM MDT Abstract 007 - Verbal Abilities at Age 6-years-old of Children of Women with vs. Without Epilepsy in the MONEAD Study
Kimford J. Meador, MD, FAAN
04:54 PM - 05:06 PM MDT Abstract 008 - Risk and Onset Latency of Incident (New-onset) Epilepsy After Stroke in Post-9/11 U.S. Veterans: A Post-hoc Analysis of the Long-term Impact of Military-relevant Brain Injury Consortium (LIMBIC-CENC) Study Data
Manaz Rezayee
05:06 PM - 05:18 PM MDT Abstract 009 - Acute Seizures After Spontaneous Intracerebral Hemorrhage in Young Individuals: 11-year Trends and Association with Mortality
Alain Zingraff Lekoubou Looti, MD
05:18 PM - 05:30 PM MDT Abstract 010 - New-onset Vascular Events in Older People with Epilepsy Over Six Years: A Cohort Study of the Canadian Longitudinal Study on Aging (CLSA)
Jimmy Li, MD
Faculty Disclosures
Brin Freund, MD Dr. Freund has nothing to disclose.
Babak Razavi, MD, PhD Dr. Razavi has stock in CortexXus. The institution of Dr. Razavi has received research support from Neuropace.
Erin Caitlin Conrad, MD Dr. Conrad has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Epiminder. Dr. Conrad has stock in Humana. Dr. Conrad has stock in Lilly Eli. Dr. Conrad has stock in Medtronic. Dr. Conrad has stock in Merck. Dr. Conrad has stock in Nevro. Dr. Conrad has stock in Sanofi. Dr. Conrad has stock in United Health Group.
Alvydas Mikulskis No disclosure on file
Jacqueline French, MD, FAAN Dr. French has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Epilepsy Foundation. The institution of Dr. French has received research support from Epilepsy Study Consortium/ Epilepsy Foundation (Funded by UCB). The institution of Dr. French has received research support from GW/One8 Foundation/FACES. The institution of Dr. French has received research support from NINDS. The institution of Dr. French has received research support from Xenon. The institution of Dr. French has received research support from Cerevel. The institution of Dr. French has received research support from FACES. The institution of Dr. French has received research support from UCB. The institution of Dr. French has received research support from Epilepsy Study Consortium. The institution of Dr. French has received research support from UCB. Dr. French has received personal compensation in the range of $100,000-$499,999 for serving as a Chief Medical/Innovation Officer with Epilepsy Foundation. Dr. French has a non-compensated relationship as a Consultant with Angelini that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Alterity Therapeutics Limited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Bright minds Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cerecin Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cognizance Biomarkers that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Arvelle that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Beacon biosignals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Biohaven Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Bloom Science Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with BridgeBio Pharma Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant, scientific advisory board with Camp4 Therapeutics Corporation that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Scientific Advisory Board with Cerebral Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cerevel that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a SAB with Coda Biotherapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Genentech Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Crossject that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Eisai, that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Eliem Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Encoded Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with iQure Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Engrail that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a SAB with Epihunter that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a SAB with Epiminder that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Epitel Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Equilibre BioPharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Greenwich Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Grin Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with GW Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Janssen Pharmaceutica that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Jazz Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Knopp Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Lipocine that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with LivaNova that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Longboard Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Lundbeck that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Marinus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Modulight Bio that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Leal therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neumirna Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant,SAB with Neurocrine that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neuroelectrics USA Corporation that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neuronetics Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Ono Pharmaceutical Co that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Otsuka Pharmaceutical Development that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Ovid Therapeutics Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Paladin Labs Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Rapport Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Praxis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with PureTech LTY Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with SK Life Sciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Stoke that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Supernus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Takeda that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with UCB Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Ventus Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting, steering committee with Xenon that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Korro Bio Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with NeuroPro Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory board with Receptor that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory board with Sage Therpeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory Board with Third Rock Ventures that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Vida Ventures Management that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Pfizer that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Agrithera, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting with Autifony therapeutics, Unlimited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Baergic Bio that is relevant to AAN interests or activities.
Roger J. Porter, MD, FAAN Dr. Porter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Xenon. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Longboard. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Engrail. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axonis. Dr. Porter has received publishing royalties from a publication relating to health care.
Emilio Perucca Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arvelle. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GW . Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi . Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Angelini. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zogenix. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shackelford. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SKB Life Sciences. The institution of Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Arvelle. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zogenix. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Angelini. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PMI Life Sciences. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chiesi. Emilio Perucca has received publishing royalties from a publication relating to health care. Emilio Perucca has received publishing royalties from a publication relating to health care. Emilio Perucca has received publishing royalties from a publication relating to health care.
Martin Brodie Martin Brodie has nothing to disclose.
Michael A. Rogawski, MD, PhD Dr. Rogawski has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Xenon Pharmaceuticals.
Cynthia L. Harden, MD Dr. Harden has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. Dr. Harden has stock in Xenon Pharmaceuticals Inc.. Dr. Harden has received intellectual property interests from a discovery or technology relating to health care.
Jenny Qian Ms. Qian has received personal compensation for serving as an employee of Xenon Pharmaceuticals.
Constanza Luzon Constanza Luzon has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. Constanza Luzon has stock in Xenon Pharmaceuticals.
Christopher Kenney Christopher Kenney has received personal compensation for serving as an employee of Xenon Pharmaceuticals.
Gregory N. Beatch, PhD Dr. Beatch has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc. Dr. Beatch has stock in Xenon Pharmaceuticals Inc. Dr. Beatch has received intellectual property interests from a discovery or technology relating to health care.
Manjit McNeill Manjit McNeill has nothing to disclose.
Kimford J. Meador, MD, FAAN The institution of Dr. Meador has received research support from NIH. The institution of Dr. Meador has received research support from Eisai. The institution of Dr. Meador has received research support from Medtronics. The institution of Dr. Meador has received research support from The Epilepsy Consortium.
Morris Cohen Morris Cohen has received publishing royalties from a publication relating to health care. Morris Cohen has received publishing royalties from a publication relating to health care.
David W. Loring, PhD, FAAN Dr. Loring has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. Dr. Loring has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ILAE. The institution of Dr. Loring has received research support from NIH. Dr. Loring has received publishing royalties from a publication relating to health care.
Carrie Brown Carrie Brown has received personal compensation for serving as an employee of Emmes.
Chelsea Robalino Chelsea Robalino has received personal compensation for serving as an employee of Emmes.
Abigail G. Matthews, PhD Dr. Matthews has received personal compensation for serving as an employee of The Emmes Company, LLC.
Page B. Pennell, MD, FAAN The institution of Dr. Pennell has received research support from NIH. The institution of an immediate family member of Dr. Pennell has received research support from Department of Defense. The institution of an immediate family member of Dr. Pennell has received research support from Environmental Protection Agency. The institution of an immediate family member of Dr. Pennell has received research support from NIH. The institution of an immediate family member of Dr. Pennell has received research support from Advanced Energy Consortium. Dr. Pennell has received publishing royalties from a publication relating to health care.
Andrea Carmack Ms. Carmack has nothing to disclose.
Eng King Tan No disclosure on file
Paula Emanuela Voinescu, MD The institution of Dr. Voinescu has received research support from Epilepsy Foundation of New England. The institution of Dr. Voinescu has received research support from BWH - Connors Center. The institution of an immediate family member of Dr. Voinescu has received research support from American Epilepsy Society. Dr. Voinescu has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Physicians' Education Resouce. Dr. Voinescu has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Phillipines League Against Epilepsy. Dr. Voinescu has a non-compensated relationship as a Board Member and Chair with My Epilepsy Story that is relevant to AAN interests or activities. Dr. Voinescu has a non-compensated relationship as a Speaker with Epilepsy Foundation that is relevant to AAN interests or activities. Dr. Voinescu has a non-compensated relationship as a Grant Reviewer with Epilepsy Ireland that is relevant to AAN interests or activities. Dr. Voinescu has a non-compensated relationship as a Grant Reviewer with American Epilepsy Society that is relevant to AAN interests or activities. Dr. Voinescu has a non-compensated relationship as a Member of Scientific Advisory Committee with North American AED Pregnancy Registry that is relevant to AAN interests or activities.
Alison M. Pack, MD, FAAN An immediate family member of Dr. Pack has received personal compensation for serving as an employee of REGENEXBIO. The institution of Dr. Pack has received research support from National Institutes of Health. Dr. Pack has received publishing royalties from a publication relating to health care.
Elizabeth Gerard, MD Dr. Gerard has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Greenwich Pharmaceuticals. The institution of Dr. Gerard has received research support from NIH/NINDS. The institution of Dr. Gerard has received research support from Xenon Pharmaceuticals. The institution of an immediate family member of Dr. Gerard has received research support from NIH. The institution of an immediate family member of Dr. Gerard has received research support from Novo Nordisk. The institution of Dr. Gerard has received research support from Eisai, Inc. (via Stanford University).
Laura A. Kalayjian, MD The institution of Dr. Kalayjian has received research support from NIH.
Angela K. Birnbaum, PhD The institution of Dr. Birnbaum has received research support from National Institutes of Health. Dr. Birnbaum has received intellectual property interests from a discovery or technology relating to health care.
Alice Keller Henning, Other The institution of Ms. Henning has received research support from NINDS/NICHD.
Christopher Gabriel No disclosure on file
Fenny L. Yudiarto, MD, PhD, FAAN Dr. Yudiarto has nothing to disclose.
Harish Babu, MD,PhD Dr. Babu has nothing to disclose.
Robert Beach, MD, PhD, FAAN The institution of Dr. Beach has received research support from Neurona.
Sharona Ben-Haim No disclosure on file
Kim Burchiel Kim Burchiel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurona Therapeutics. Kim Burchiel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ClearPoint Neuro. Kim Burchiel has received intellectual property interests from a discovery or technology relating to health care. Kim Burchiel has received publishing royalties from a publication relating to health care. Kim Burchiel has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Harvard University.
Matthew W. Luedke, MD Dr. Luedke has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bright Health. Dr. Luedke has received personal compensation in the range of $0-$499 for serving as an Expert Witness for Guidepoint. The institution of Dr. Luedke has received research support from US NAVY. The institution of Dr. Luedke has received research support from Neurona. The institution of Dr. Luedke has received research support from Xenon.
Rebecca O'Dwyer, MD Dr. O'Dwyer has nothing to disclose.
Sepehr Sani Sepehr Sani has nothing to disclose.
Jerry J. Shih, MD, FAAN Dr. Shih has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. Dr. Shih has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurelis. Dr. Shih has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SK Life. Dr. Shih has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. The institution of Dr. Shih has received research support from Neurona. The institution of Dr. Shih has received research support from NCGS, Inc. Dr. Shih has a non-compensated relationship as a Test Writing Committee Member with ABPN that is relevant to AAN interests or activities.
Derek Southwell, MD,PhD Dr. Southwell has nothing to disclose.
David C. Spencer, MD, FAAN Dr. Spencer has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroPace Inc. Dr. Spencer has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Spencer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Various. Dr. Spencer has received publishing royalties from a publication relating to health care. Dr. Spencer has received personal compensation in the range of $500-$4,999 for serving as a Faculty in Teaching Course supported by unrestricted educational grants with Creative Education Concepts.
Gautam Banik, PhD Dr. Banik has received personal compensation for serving as an employee of Neurona Therapeutics. Dr. Banik has stock in Neurona Therapeutics.
Marina Bershteyn, PhD Dr. Bershteyn has received personal compensation for serving as an employee of Neurona therapeutics . Dr. Bershteyn has received stock or an ownership interest from Neurona therapeutics . The institution of Dr. Bershteyn has received research support from CIRM.
David E. Blum, MD Dr. Blum has received personal compensation for serving as an employee of Neurona Therapeutics. Dr. Blum has stock in Neurona Therapeutics.
Alessandro Bulfone, MD Dr. Bulfone has received personal compensation for serving as an employee of Neurona Therapeutics Inc.
Brianna Feld Miss Feld has received personal compensation for serving as an employee of Neurona Therapeutics.
Holly Finefrock Ms. Finefrock has received personal compensation for serving as an employee of Neurona Therapeutics.
Luis Fuentealba Luis Fuentealba has received personal compensation for serving as an employee of Neurona Therapeutics.
John David Hixson, MD Dr. Hixson has received personal compensation for serving as an employee of Neurona Therapeutics. Dr. Hixson has received personal compensation for serving as an employee of Nile Ai. Dr. Hixson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NextSense Inc.. Dr. Hixson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Seer Medical. Dr. Hixson has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Expert Institute.
Victoria Hosford Miss Hosford has received personal compensation for serving as an employee of Neurona Therapeutics.
Ji-Hye Jung, PhD Dr. Jung has received personal compensation for serving as an employee of Neurona Therapeutics.
Tia Kowal, PhD Dr. Kowal has received personal compensation for serving as an employee of Neurona Theraputics.
Sonja Kriks, PhD Ms. Kriks has received personal compensation for serving as an employee of Neurona Therapeutics. Ms. Kriks has stock in Neurona Therapeutics. Ms. Kriks has received intellectual property interests from a discovery or technology relating to health care.
Rose D. Larios, PhD Dr. Larios has received personal compensation for serving as an employee of Neurona Therapeutics. Dr. Larios has stock in Neurona Therapeutics.
Seonok Lee, PhD Dr. Lee has received personal compensation for serving as an employee of Neurona Therapeutics.
Sheri Madrid Mrs. Madrid has received personal compensation for serving as an employee of Neurona Therapeutics, Inc. Mrs. Madrid has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurona Therapeutics, Inc.
Yves Maury, PhD Mr. MAURY has received personal compensation for serving as an employee of neurona therapeutics.
Catherine Priest Catherine Priest has received personal compensation for serving as an employee of Neurona Therapeutics. Catherine Priest has received stock or an ownership interest from Neurona Therapeutics.
Kiril Shevchuk Mr. Shevchuk has received personal compensation for serving as an employee of Neurona Therapeutics.
Sergei Shevchuk, PhD Dr. Shevchuk has received personal compensation for serving as an employee of Neurona Therapeutics.
Cory R Nicholas, PhD Dr. Nicholas has received personal compensation for serving as an employee of Neurona Therapeutics. Dr. Nicholas has stock in Neurona Therapeutics. Dr. Nicholas has received intellectual property interests from a discovery or technology relating to health care.
Mochammad Machfoed No disclosure on file
Alain Zingraff Lekoubou Looti, MD Dr. Lekoubou Looti has nothing to disclose.
Austin Cohrs, Other Mr. Cohrs has nothing to disclose.
Darwin Amir, MD, FAAN No disclosure on file
Terence John O'Brien, MD The institution of Prof. O'Brien has received research support from Eisai. The institution of Prof. O'Brien has received research support from UCB. The institution of Prof. O'Brien has received research support from BioGen. The institution of Prof. O'Brien has received research support from ES Theraputics. The institution of an immediate family member of Prof. O'Brien has received research support from Epidarex.
Emma Foster, MD, MBBS The institution of Dr. Foster has received research support from Monash University Bridging Postdoctoral Fellowship. The institution of Dr. Foster has received research support from Sylvia and Charles Viertel Charitable Foundation. The institution of Dr. Foster has received research support from Brain Foundation (Australia). The institution of Dr. Foster has received research support from Australian Epilepsy Research Fund. The institution of Dr. Foster has received research support from LivaNova. The institution of Dr. Foster has received research support from Lundbeck Australia.
Lyn Millist Ms. Millist has nothing to disclose.
Jack Germaine, RN Mr. Germaine has nothing to disclose.
Stephanie Chamorro, RN Mrs. Chamorro has nothing to disclose.
Caitlin Roberts, RN Miss Roberts has nothing to disclose.
John-Paul Nicolo, MBBS Dr. Nicolo has nothing to disclose.
Sean James Kenny Sean, RN Mr. Sean has nothing to disclose.
Piero Perucca, MD The institution of Dr. Perucca has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chiesi. The institution of Dr. Perucca has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. The institution of Dr. Perucca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. The institution of Dr. Perucca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Perucca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for LivaNova. The institution of Dr. Perucca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chiesi. The institution of Dr. Perucca has received research support from NHMRC. The institution of Dr. Perucca has received research support from Epilepsy Foundation. The institution of Dr. Perucca has received research support from Royal Australasian College of Physicians. The institution of Dr. Perucca has received research support from Melbourne Health. The institution of Dr. Perucca has received research support from Monash University. The institution of Dr. Perucca has received research support from Epilepsy Foundation . The institution of Dr. Perucca has received research support from Victorian Medical Research Acceleration Fund. The institution of Dr. Perucca has received research support from Sanming Project Grant, Shenzhen government. The institution of Dr. Perucca has received research support from Brain Australia. The institution of Dr. Perucca has received research support from Medical Research Future Fund. The institution of Dr. Perucca has received research support from Weary Dunlop Medical Research Foundation. The institution of Dr. Perucca has received research support from Norman Beischer Medical Research Foundation. The institution of Dr. Perucca has received research support from NHMRC. The institution of Dr. Perucca has received research support from Austin Medical Research Foundation.
Saul Mullen, PhD,MBBS Dr. Mullen has nothing to disclose.
Heather Robinson, RN Ms. Robinson has nothing to disclose.
Rebecca Wharrie, RN Miss Wharrie has nothing to disclose.
Brittany Walsh, RN Mrs. Walsh has nothing to disclose.
David C. Reutens, MD The institution of Dr. Reutens has received research support from Australian Research Council. The institution of Dr. Reutens has received research support from Siemens Health Care. The institution of Dr. Reutens has received research support from Vivazone Pty Ltd. Dr. Reutens has received intellectual property interests from a discovery or technology relating to health care.
Kimberley Jane Irwin, RN Mrs. Irwin has nothing to disclose.
Michael Chen No disclosure on file
Robert Niecestro, PhD Dr. Niecestro has received personal compensation for serving as an employee of ES Therapeutics. Dr. Niecestro has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Cyprium Therapeutics. Dr. Niecestro has received research support from ES Therapeutics.
Siswanto No disclosure on file
Jacqueline Hirschey, MD Dr. Hirschey has nothing to disclose.
Megan Amuan Megan Amuan has nothing to disclose.
Zulfi Haneef, MD, MBBS, MRCP, FAAN Dr. Haneef has nothing to disclose.
Linda S. Williams, MD, FAAN The institution of Dr. Williams has received research support from VA HSR&D.
Ian Stewart The institution of Ian Stewart has received research support from Department of Defense. Ian Stewart has received intellectual property interests from a discovery or technology relating to health care.
Marissa Kellogg, MD, MPH Dr. Kellogg has nothing to disclose.
Mary Jo Pugh, PhD, RN, FAAN The institution of Dr. Pugh has received research support from Department of Defense, Epilepsy Research Program. The institution of Dr. Pugh has received research support from VA Health Services Research and Development Service. The institution of Dr. Pugh has received research support from VA Rehabilitation Research and Development Service. The institution of Dr. Pugh has received research support from Congressionally Directed Research Programs. The institution of Dr. Pugh has received research support from Sanofi.
Elisabeth Wilde Elisabeth Wilde has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neuropsychology. The institution of Elisabeth Wilde has received research support from CDMRP/DoD. The institution of Elisabeth Wilde has received research support from VA. The institution of Elisabeth Wilde has received research support from NIH. The institution of Elisabeth Wilde has received research support from Cohen Veteran Biosciences.
Eamonn Kennedy, PhD Dr. Kennedy has nothing to disclose.
Manaz Rezayee Ms. Rezayee has nothing to disclose.
Jale Agaoglu, MD No disclosure on file
Jimmy Li, MD Dr. Li has received research support from Fonds de recherche du Québec - Santé. Dr. Li has received research support from Brain Canada.
Nathan A. Shlobin Mr. Shlobin has nothing to disclose.
Roland Thijs The institution of Roland Thijs has received research support from EpilepsieNL. The institution of Roland Thijs has received research support from ZonMW. Roland Thijs has received personal compensation in the range of $500-$4,999 for serving as a Speaker with UCB. Roland Thijs has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Novartis. Roland Thijs has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Angellini.
Charles Deacon, MD Dr. Deacon has nothing to disclose.
Mark Robert Keezer, MD, PhD The institution of Dr. Keezer has received research support from UCB . The institution of Dr. Keezer has received research support from Eisai. The institution of Dr. Keezer has received research support from TD Bank. The institution of Dr. Keezer has received research support from Savoy Foundation. The institution of Dr. Keezer has received research support from TSC Alliance. The institution of Dr. Keezer has received research support from Quebec Bio-imaging Network. The institution of Dr. Keezer has received research support from Canadian Institutes of Health Research. The institution of Dr. Keezer has received research support from Fonds de Recherche Québec Santé. The institution of Dr. Keezer has received research support from Canadian Institutes of Health Research.